GCM
KURA icon

Graham Capital Management’s Kura Oncology KURA Stock Holding History

Graham Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,463
Closed -$137K – 1429
2025
Q3 		$137K Sell
15,463
-132,459
-90% -$944K ﹤0.01% 1130
2025
Q2 		$854K Sell
147,922
-26,637
-15% -$163K 0.01% 631
2025
Q1 		$1.15M Buy
174,559
+123,610
+243% +$963K 0.02% 506
2024
Q4 		$444K Buy
+50,949
New +$733K 0.01% 781
2024
Q2 		– Sell
-10,172
Closed -$217K – 1209
2024
Q1 		$217K Buy
+10,172
New +$198K ﹤0.01% 876
2023
Q4 		– Sell
-21,131
Closed -$193K – 1172
2023
Q3 		$193K Sell
21,131
-9,487
-31% -$96.3K ﹤0.01% 862
2023
Q2 		$324K Buy
+30,618
New +$362K 0.01% 658
2022
Q2 		– Sell
-14,376
Closed -$231K – 1140
2022
Q1 		$231K Buy
+14,376
New +$208K 0.01% 801

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Graham Capital Management's KURA Position: Q4 2025 in Review

Graham Capital Management sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 15,463 shares — an estimated $137K sold.

Graham Capital Management first reported a position in KURA in Q1 2022 and held it in 8 quarters. The position peaked at $1.15M in Q1 2025. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Graham Capital Management reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 15,463 Kura Oncology shares in Q4 2025, an estimated $137K.
  • Graham Capital Management first reported a position in Kura Oncology in Q1 2022 and held it in 8 quarters.
  • Graham Capital Management's Kura Oncology position peaked at $1.15M in Q1 2025.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.